It doesnt matter a zac what their revenue was previously.
They only got FDA approval a few months ago. They couldnt sell the xv technology on a commercial basis without it.
The whole purpose of this raise is to begin the commercial rollout.
Given their lung imaging tech is the only tech that can clearly see where and how badly covid has damaged the lungs I can envisage there would be a rapid take up in the USA.
4dx is the next level in lung imaging. It has huge advantages over x ray and ct scan. A no brainer.
It doesnt matter a zac what their revenue was previously. They...
-
- There are more pages in this discussion • 2,815 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
26.0¢ |
Change
-0.005(1.89%) |
Mkt cap ! $121.0M | |||
| Open | High | Low | Value | Volume |
| 26.5¢ | 26.5¢ | 25.5¢ | $378.8K | 1.444M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 218499 | 25.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.5¢ | 296560 | 2 |
View Market Depth
| Last trade - 15.58pm 18/06/2025 (20 minute delay) ? |
| 4DX (ASX) Chart |